Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-28 7:39 pm Unchanged | 13D | Carisma Therapeutics Inc. CARM | HealthCap VII L.P. | 3,398,248 8.200% | 0 (Unchanged) | View |
| 2024-03-13 4:30 pm Purchase | 13G | Carisma Therapeutics Inc. CARM | AbbVie Biotechnology Ltd | 2,749,855 6.800% | 2,749,855 (New Position) | View |
| 2024-03-07 4:05 pm Unchanged | 13D | Carisma Therapeutics Inc. CARM | HealthCap VII L.P. | 3,398,248 8.400% | 0 (Unchanged) | View |
| 2024-02-13 5:00 pm Purchase | 13G | Carisma Therapeutics Inc. CARM | VANGUARD GROUP INC | 1,568,761 3.890% | 1,568,761 (New Position) | View |
| 2024-02-02 1:06 pm Sale | 13G | Carisma Therapeutics Inc. CARM | Longview Innovation Corp. | 2,713,232 6.700% | -182,033 (-6.29%) | View |
| 2024-01-26 4:31 pm Sale | 13D | Carisma Therapeutics Inc. CARM | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 1,252,107 3.100% | -930,705 (-42.64%) | View |
| 2023-03-22 11:13 am Sale | 13D | Carisma Therapeutics Inc. CARM | HealthCap VII L.P. | 3,398,248 8.400% | -181,363 (-5.07%) | View |
| 2023-03-17 4:10 pm Purchase | 13D | Carisma Therapeutics Inc. CARM | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2,182,812 5.420% | 2,182,812 (New Position) | View |
| 2023-03-16 4:08 pm Purchase | 13G | Carisma Therapeutics Inc. CARM | Longview Innovation Corp. | 2,895,265 7.200% | 2,895,265 (New Position) | View |
| 2023-03-13 5:12 pm Purchase | 13G | Carisma Therapeutics Inc. CARM | ModernaTX Inc. | 5,059,338 12.570% | 5,059,338 (New Position) | View |
| 2023-03-09 10:33 am Purchase | 13D | Carisma Therapeutics Inc. CARM | HealthCap VII L.P. | 3,579,611 8.900% | 3,579,611 (New Position) | View |
| 2023-02-15 4:54 pm Purchase | 13D | Carisma Therapeutics Inc. CARM | Radoff Bradley Louis | 9,300,100 4.600% | 385,000 (+4.32%) | View |
| 2023-02-09 11:32 am Sale | 13G | Carisma Therapeutics Inc. CARM | VANGUARD GROUP INC | 10,854,300 5.350% | -1,512,456 (-12.23%) | View |
| 2023-01-26 09:25 am Purchase | 13D | Carisma Therapeutics Inc. CARM | Radoff Bradley Louis | 8,915,100 4.400% | 273,235 (+3.16%) | View |
| 2023-01-05 2:38 pm Purchase | 13D | Carisma Therapeutics Inc. CARM | Radoff Bradley Louis | 8,641,865 4.300% | 1,141,765 (+15.22%) | View |
| 2022-12-01 3:39 pm Purchase | 13D | Carisma Therapeutics Inc. CARM | Radoff Bradley Louis | 7,500,100 3.700% | 1,500,100 (+25.00%) | View |
| 2022-11-18 1:31 pm Purchase | 13D | Carisma Therapeutics Inc. CARM | Radoff Bradley Louis | 6,000,000 3.000% | 6,000,000 (New Position) | View |
| 2022-07-08 4:56 pm Sale | 13G | Carisma Therapeutics Inc. CARM | BlackRock Inc. BLK | 4,088,667 2.000% | -9,399,937 (-69.69%) | View |
| 2022-02-10 08:37 am Purchase | 13G | Carisma Therapeutics Inc. CARM | VANGUARD GROUP INC | 12,366,756 6.200% | 12,366,756 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Carisma Therapeutics Inc. CARM | BlackRock Inc. BLK | 13,488,604 6.800% | 13,488,604 (New Position) | View |